| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |